PreComb Therapeutics

About:

PreComb develops technologies to optimally adapt the therapies to each patient for difficult to treat cancers.

Website: https://www.precomb.com/contact/

Twitter/X: Precomb_AG

Top Investors: LongeVC, HTGF | High-Tech Gruenderfonds, Kinled Holding, FiveT Capital AG

Description:

PreComb develops technologies to optimally adapt the therapies to each patient for difficult to treat cancers to increase the success rates in cancer therapy. Only an efficient use of healthcare resources can lead to a maximum improvement in the quality of life of patients.

Total Funding Amount:

3.5M CHF

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Hombrechtikon, Zurich, Switzerland

Founded Date:

2018-01-01

Contact Email:

info(AT)precomb.com

Founders:

Jens Kelm, Peter Steiner

Number of Employees:

11-50

Last Funding Date:

2022-10-04

IPO Status:

Private

Industries:

© 2025 bioDAO.ai